We have also observed that in vivo, the effect of the CaSR modulators depend on an inflamed environment, as treatment with the CaSR modulators affected certain PGE2 pathway genes only in the colons of mice with DSS-induced colitis, but not in the colons of mice without colitis, indicating a selective action of the CaSR in an inflamed environment. Here, CASR is linked to colitis.